Canadian Company Initiates Clinical Trial Using an Expanded Cord Blood for Acute Myeloid Leukemia (AML)

Canadian Company Initiates Clinical Trial Using an Expanded Cord Blood for Acute Myeloid Leukemia (AML)

Research Update- AML Trial ExCellThera is a clinical stage biotech company that is focused on developing a robust and cost effective technology to expand blood stem cells from cord blood for therapeutic use. ExCellThera is a spin-off company from the Institute for...
add chat to your website

Get Info Pack

Take the first step to learn about cord blood and cord tissue banking today!

Blog leukemia